Goldfarb, David S. http://orcid.org/0000-0002-9215-1273
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U54DK083908-01)
Article History
Received: 3 September 2018
Accepted: 8 November 2018
First Online: 26 November 2018
Compliance with ethical standards
:
: Goldfarb: consultant: Alnylam, Retrophin; funding from NIDDK, NCATS.